0 NASDAQ Companies - February 1, 2024Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage […]Read More
0 NASDAQ Companies - February 1, 2024Hillman Sets Fourth Quarter 2023 Earnings Release and Results Presentation DateCINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and […]Read More
0 NASDAQ Companies - February 1, 2024Purple Biotech Reaches Recommended Phase 2 Dose for NT219REHOVOT, Israel, Feb. 01, 2024 (GLOBE NEWSWIRE) — Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage […]Read More
0 NASDAQ Companies - February 1, 2024Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024CINCINNATI, Feb. 01, 2024 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based […]Read More
0 NASDAQ Companies - February 1, 2024Kelly Announces Fourth-Quarter Conference CallTROY, Mich., Feb. 01, 2024 (GLOBE NEWSWIRE) — Kelly, a leading global specialty talent solutions provider, will release its fourth-quarter […]Read More
0 NASDAQ Companies - February 1, 2024Dyne Therapeutics to Present at February Investor ConferencesWALTHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]Read More
0 NASDAQ Companies - February 1, 2024Allegro MicroSystems Reports Third Quarter 2024 Results–Total Sales Increased 2% Year-over-Year ––E-Mobility Drives 18% Year-over-Year Increase in Automotive Sales – MANCHESTER, N.H., Feb. 01, 2024 (GLOBE […]Read More
0 NASDAQ Companies - February 1, 2024Nxu Provides Business Update Following 2023 Fiscal Year EndMESA, Ariz., Feb. 01, 2024 (GLOBE NEWSWIRE) — Nxu Inc. (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company developing […]Read More
0 NASDAQ Companies - February 1, 2024Verve Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceBOSTON, Feb. 01, 2024 (GLOBE NEWSWIRE) — Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care […]Read More
0 NASDAQ Companies - February 1, 2024FirstCash Reports Fourth Quarter and Full-Year Operating Results; Record Pawn Receivables Drive Strong Revenue and Earnings Growth; Company Adds 157 Pawn Stores in 2023; Declares Quarterly Cash DividendFORT WORTH, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) — FirstCash Holdings, Inc. (“FirstCash” or the “Company”) (Nasdaq: FCFS), the leading […]Read More